Eisai

Anonymous board for Eisai.
Post thread


Why are so many leaving recently and where is everyone going?
Replies
10
Views
2K
anonymous
Jennifer Simier
Replies
0
Views
457
anonymous
Novo’s GLP-1 drug liraglutide slows cognitive decline by 18% in mid-stage Alzheimer's study
Replies
1
Views
301
anonymous
European Medicines Agency rejects breakthrough Alzheimer’s drug
Replies
6
Views
795
anonymous
Join IT or pass
Replies
2
Views
364
anonymous
The end of the beginning: Lilly execs eye top spot in burgeoning Alzheimer's market after Kisunla's FDA approval | Fierce Pharma
Replies
5
Views
626
anonymous
Fierce Pharma - Lilly tipped to beat Eisai, Biogen, win $13B Alzheimer's fight
Replies
13
Views
1K
anonymous
Eisai and Bristol Myers cancel cancer ADC deal | BioPharma Dive
Replies
4
Views
600
anonymous
FDA approves Eli Lilly's Alzheimer’s drug that slows memory decline
Replies
2
Views
458
anonymous
Getting bamboozled on bonus
Replies
32
Views
4K
anonymous
Alzheimer's drug has potentially fatal side effects - Los Angeles Times
Replies
2
Views
389
anonymous
It's the first drug shown to slow Alzheimer's. Why is it off to a slow start? | AP News
Replies
11
Views
1K
anonymous
Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024
Replies
9
Views
1K
anonymous
Real-world prescribing of lecanemab in the United States - Truveta
Replies
2
Views
643
anonymous
Why so many openings
Replies
6
Views
1K
anonymous
FiercePharma: Leqembi launch hamstrung by physicians' 'therapeutic nihilism'
Replies
5
Views
830
anonymous
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
Replies
0
Views
408
anonymous
Eisai home office?
Replies
10
Views
3K
anonymous
Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s | BioSpace
Replies
1
Views
684
anonymous
Is Leqembi for Alzheimer’s Disease Worth the Hype?
Replies
3
Views
1K
anonymous
Top Bottom
Back
Post thread